Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis

by Benjamin Rix Brooks, James D. Berry, Malgorzata Ciepielewska, Ying Liu, Gustavo Suarez Zambrano, Jeffrey Zhang, Melissa Hagan
Published 2022-10-01

Assessing Oromotor Capacity in ALS: The Effect of a Fixed-Target Task on Lip Biomechanics

by Marziye Eshghi, Kaila L. Stipancic, Antje Mefferd, Panying Rong, James D. Berry, Yana Yunusova, Jordan R. Green
Published 2019-12-01

Preclinical rodent toxicity studies for long term use of ceftriaxone

by Elena Ratti, James D. Berry, David J. Greenblatt, Lorena Loci, Amy Swartz Ellrodt, Jeremy M. Shefner, Merit E. Cudkowicz
Published 2015-01-01

Two Distinct Clinical Phenotypes of Bulbar Motor Impairment in Amyotrophic Lateral Sclerosis

by Kaila L. Stipancic, Kaila L. Stipancic, Yana Yunusova, Thomas F. Campbell, Jun Wang, James D. Berry, Jordan R. Green
Published 2021-06-01

Predicting Speech Intelligibility Decline in Amyotrophic Lateral Sclerosis Based on the Deterioration of Individual Speech Subsystems.

by Panying Rong, Yana Yunusova, Jun Wang, Lorne Zinman, Gary L Pattee, James D Berry, Bridget Perry, Jordan R Green
Published 2016-01-01

Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry’s Research Notification M...

by Paul Mehta, Jaime Raymond, Moon Kwon Han, Theodore Larson, James D Berry, Sabrina Paganoni, Hiroshi Mitsumoto, Richard Stanley Bedlack, D Kevin Horton
Published 2021-12-01

Protocol for psychometric evaluation of the Amyotrophic Lateral Sclerosis - Bulbar Dysfunction Index (ALS-BDI): a prospective longitudinal study

by James D Berry, Rosemary Martino, Carolina Barnett, Lorne Zinman, Yana Yunusova, Ashley Waito, Anna Huynh, Agessandro Abrahao, Gary L Pattee, Jordan R Green
Published 2022-03-01

Design and results of a smartphone‐based digital phenotyping study to quantify ALS progression

by James D. Berry, Sabrina Paganoni, Kenzie Carlson, Katherine Burke, Harli Weber, Patrick Staples, Joel Salinas, James Chan, Jordan R. Green, Kathryn Connaghan, Josh Barback, Jukka Pekka Onnela
Published 2019-05-01

Upper limb movements as digital biomarkers in people with ALSResearch in context

by Marcin Straczkiewicz, Marta Karas, Stephen A. Johnson, Katherine M. Burke, Zoe Scheier, Tim B. Royse, Narghes Calcagno, Alison Clark, Amrita Iyer, James D. Berry, Jukka-Pekka Onnela
Published 2024-03-01

Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures

by Stephen A. Johnson, Marta Karas, Katherine M. Burke, Marcin Straczkiewicz, Zoe A. Scheier, Alison P. Clark, Satoshi Iwasaki, Amir Lahav, Amrita S. Iyer, Jukka-Pekka Onnela, James D. Berry
Published 2023-03-01

Rate of speech decline in individuals with amyotrophic lateral sclerosis

by Marziye Eshghi, Yana Yunusova, Kathryn P. Connaghan, Bridget J. Perry, Marc F. Maffei, James D. Berry, Lorne Zinman, Sanjay Kalra, Lawrence Korngut, Angela Genge, Annie Dionne, Jordan R. Green
Published 2022-09-01

Using Smartphones to Reduce Research Burden in a Neurodegenerative Population and Assessing Participant Adherence: A Randomized Clinical Trial and Two Observational Studies

by Anna L Beukenhorst, Katherine M Burke, Zoe Scheier, Timothy M Miller, Sabrina Paganoni, Mackenzie Keegan, Ella Collins, Kathryn P Connaghan, Anna Tay, James Chan, James D Berry, Jukka-Pekka Onnela
Published 2022-02-01

Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALS

by Anne Marie Wills, Jamie Garry, Jane Hubbard, Taylor Mezoian, Christopher T. Breen, Courtney Ortiz-Miller, Paige Nalipinski, Stacey Sullivan, James D. Berry, Merit Cudkowicz, Sabrina Paganoni, James Chan, Eric A. Macklin
Published 2019-05-01

Tracking amyotrophic lateral sclerosis disease progression using passively collected smartphone sensor data

by Marta Karas, Julia Olsen, Marcin Straczkiewicz, Stephen A. Johnson, Katherine M. Burke, Satoshi Iwasaki, Amir Lahav, Zoe A. Scheier, Alison P. Clark, Amrita S. Iyer, Emily Huang, James D. Berry, Jukka‐Pekka Onnela
Published 2024-06-01

Longitudinal biomarkers in amyotrophic lateral sclerosis

by Fen Huang, Yuda Zhu, Jennifer Hsiao‐Nakamoto, Xinyan Tang, Jason C. Dugas, Miriam Moscovitch‐Lopatin, Jonathan D. Glass, Robert H. Brown Jr, Shafeeq S. Ladha, David Lacomis, Jeffrey M. Harris, Kimberly Scearce‐Levie, Carole Ho, Robert Bowser, James D. Berry
Published 2020-07-01

Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons

by Brian J. Wainger, Evangelos Kiskinis, Cassidy Mellin, Ole Wiskow, Steve S.W. Han, Jackson Sandoe, Numa P. Perez, Luis A. Williams, Seungkyu Lee, Gabriella Boulting, James D. Berry, Robert H. Brown Jr., Merit E. Cudkowicz, Bruce P. Bean, Kevin Eggan, Clifford J. Woolf
Published 2014-04-01

Face and content validation of the amyotrophic lateral sclerosis—Bulbar dysfunction index (ALS-BDI)

by Yana Yunusova, Yana Yunusova, Yana Yunusova, Ashley Waito, Carolina Barnett Tapia, Carolina Barnett Tapia, Anna Huynh, Anna Huynh, Anna Huynh, Rosemary Martino, Rosemary Martino, Rosemary Martino, Agessandro Abrahao, Agessandro Abrahao, Gary L. Pattee, James D. Berry, Lorne Zinman, Lorne Zinman, Jordan R. Green, Jordan R. Green
Published 2023-01-01

Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis.

by James D Berry, Jeremy M Shefner, Robin Conwit, David Schoenfeld, Myles Keroack, Donna Felsenstein, Lisa Krivickas, William S David, Francine Vriesendorp, Alan Pestronk, James B Caress, Jonathan Katz, Ericka Simpson, Jeffrey Rosenfeld, Robert Pascuzzi, Jonathan Glass, Kourosh Rezania, Jeffrey D Rothstein, David J Greenblatt, Merit E Cudkowicz, Northeast ALS Consortium
Published 2013-01-01

Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial

by Suma Babu, Baileigh G. Hightower, James Chan, Nicole R. Zürcher, Pia Kivisäkk, Chieh-En J. Tseng, Danica L. Sanders, Ashley Robichaud, Haruhiko Banno, Armineuza Evora, Akshata Ashokkumar, Lindsay Pothier, Sabrina Paganoni, Sheena Chew, Joanna Dojillo, Kazuko Matsuda, Mark Gudesblatt, James D. Berry, Merit E. Cudkowicz, Jacob M Hooker, Nazem Atassi
Published 2021-01-01

A Phase 1 study of GDC‐0134, a dual leucine zipper kinase inhibitor, in ALS

by Jonathan S. Katz, Jeffrey D. Rothstein, Merit E. Cudkowicz, Angela Genge, Björn Oskarsson, Avis B. Hains, Chen Chen, Joshua Galanter, Braydon L. Burgess, William Cho, Geoffrey A. Kerchner, Felix L. Yeh, Arundhati Sengupta Ghosh, Sravanthi Cheeti, Logan Brooks, Lee Honigberg, Jessica A. Couch, Michael E. Rothenberg, Flavia Brunstein, Khema R. Sharma, Leonard van denBerg, James D. Berry, Jonathan D. Glass
Published 2022-01-01